Newsletter | February 11, 2025

02.11.25 -- 2024 Trends In FDA Observations For Sterile Drug Manufacturers

SPONSOR

Webinar: Who’s In Charge of Your Trial? How to Ensure Effective Oversight and Leadership

Clinical trials in complex therapeutic areas require more than just a solid strategy—they demand proactive and engaged operational leadership from the sponsor side. Join our expert panel to discuss how an active and knowledgeable Clin Ops lead, in collaboration with an experienced outsourcing project lead, can drive informed decision-making, enhance efficiency, and ultimately ensure trial success. Click to learn more.

FEATURED EDITORIAL

2024 Trends In FDA Observations For Sterile Drug Manufacturers

By Marzena Ingram, Eliquent Life Sciences; Ajay Pazhayattil, Ph.D., cGMPWorld; Prasanna Sagar, Ph.D., ITAAN Pharma; and Subrata Chakraborty, Ph.D., INOPHAR Consulting

This data-driven analysis of the 2024 trends in FDA observations for sterile drug manufacturers includes a comparison to the 2023 trends. Which 21 CFR 211 sections surprise you most?

INDUSTRY INSIGHTS

Planning For The Return And Destruction Of Your Product

Article | PCI Pharma Services

Aspects of accountability, reconciliation, return, and destruction require significant effort to compile historical data. A little up-front planning can remove many future complications.

Impact Of Supplier Choice On APAC Clinical Trial Execution

Webinar | Catalent

Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.

SOLUTIONS

Navigating The Use Of Controlled Substances In Clinical Trials Using IRT

IQVIA Technologies

Gain Complete Control of Supplies

Signant Health

Pharmaceutical Clinical Trial Distribution Services

Ropack Pharma Solutions